ACSS2 and gastric cancer: Surprisingly, loss of ACSS2 expression was identified in a high proportion of gastric cancers (62.6%), whereas this was more commonly observed in poorly differentiated gastric adenocarcinoma or signet ring cell carcinoma (19).